Form 8-K - Current report:
SEC Accession No. 0001144204-16-103462
Filing Date
2016-05-19
Accepted
2016-05-19 06:01:17
Documents
24
Period of Report
2016-05-19
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K v440324_8k.htm 8-K 14948
2 EXHIBIT 99.1 v440324_ex99-1.htm EX-99.1 30604
3 GRAPHIC image_001.jpg GRAPHIC 78798
4 GRAPHIC image_002.jpg GRAPHIC 121307
5 GRAPHIC image_003.jpg GRAPHIC 109896
6 GRAPHIC image_004.jpg GRAPHIC 90660
7 GRAPHIC image_005.jpg GRAPHIC 99547
8 GRAPHIC image_006.jpg GRAPHIC 86870
9 GRAPHIC image_007.jpg GRAPHIC 83310
10 GRAPHIC image_008.jpg GRAPHIC 89898
11 GRAPHIC image_009.jpg GRAPHIC 113954
12 GRAPHIC image_010.jpg GRAPHIC 109691
13 GRAPHIC image_011.jpg GRAPHIC 119901
14 GRAPHIC image_012.jpg GRAPHIC 100941
15 GRAPHIC image_013.jpg GRAPHIC 96746
16 GRAPHIC image_014.jpg GRAPHIC 104842
17 GRAPHIC image_015.jpg GRAPHIC 74582
18 GRAPHIC image_016.jpg GRAPHIC 109736
19 GRAPHIC image_017.jpg GRAPHIC 105569
20 GRAPHIC image_018.jpg GRAPHIC 111657
21 GRAPHIC image_019.jpg GRAPHIC 95731
22 GRAPHIC image_020.jpg GRAPHIC 122506
23 GRAPHIC image_021.jpg GRAPHIC 100177
24 GRAPHIC image_022.jpg GRAPHIC 77992
  Complete submission text file 0001144204-16-103462.txt   3085835
Mailing Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080
Business Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080 4152444990
TITAN PHARMACEUTICALS INC (Filer) CIK: 0000910267 (see all company filings)

EIN.: 943171940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-13341 | Film No.: 161661844
SIC: 2836 Biological Products, (No Diagnostic Substances)